The University of Chicago Header Logo

Connection

Stephen Hanauer to Therapeutic Equivalency

Back to Details
This is a "connection" page, showing publications Stephen Hanauer has written about Therapeutic Equivalency.
Stephen Hanauer
Connection Strength
0.055
Therapeutic Equivalency
  1. Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial. Am J Clin Dermatol. 2022 Sep; 23(5):719-728.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.